TransCode Share Price

TransCode Share Price

NASDAQ: RNAZ | Micro Cap | Healthcare
$1.14
-$0.14 (-10.94%) Last updated on 21 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

TransCode Stock Performance

Open
$1.16
Prev. Close
$1.28
Circuit Range
N/A
Day Range
$1.13 - $1.16
Year Range
$1.13 - $11.97
Volume
903
Average Traded
$1.14

TransCode Share Price Today

As of 22 November 2026, TransCode Therapeutics, Inc.'s share price is $1.14. The stock opened at $1.16, compared to its previous close of $1.28. During today's trading session, TransCode Therapeutics, Inc.'s share price traded between $1.13 and $1.16, with an average price of $1.14. Over the past 52 weeks, the stock has recorded a high of $11.97 and a low of $1.13. In terms of performance, TransCode Therapeutics, Inc.'s share price has declined by 78.77% over the last six months and is down 87.41% on a year-on-year basis.

TransCode Share Price Chart

Line chart of the TransCode price trend over the selected period. The price fell overall, ranging from 1.08 to 1.22, ending at 1.14.
$1.13$1.16
L
Show Current Price
H

TransCode Stock Fundamentals & Key Indicators

Market Cap
$786272.82
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.60
Revenue (TTM)
$0.00
Return On Equity (TTM)
-462.99%
Profit Margin
N/A
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-613.49%

TransCode Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$15.05-$19.51-$6.87-$107.38
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-29.63%64.79%-1463.03%

TransCode Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.56-$18.55-$16.79-$36.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.64%9.49%-116.02%

TransCode Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets140.410.20.710.21
Current Assets21.987.094.467.38
Total Assets162.47.295.177.59
Non Current Liabilities7.026.540.040.0
Current Liabilities3.492.773.494.35
Total Liabilities10.529.313.534.35
Shareholders' Equity10.34-2.021.643.24

TransCode Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-19.52-13.34-18.07-15.76
Investing0.0-0.02-0.04-0.1
Financing31.5216.415.910.01

Corporate Actions

Split
Ex-date: 15 May 2025

Split
Ex-date: 04 Dec 2024

Split
Ex-date: 16 Jan 2024

Split
Ex-date: 23 May 2023

About TransCode

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

TransCode Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.65
$1.14
-34.86%
Oct 2026
$1.59
$1.75
+5.42%
Sep 2026
$2.10
$1.66
-41.45%
Aug 2026
$4.09
$2.83
-46.00%
Jul 2026
$6.56
$5.25
+3.35%
Jun 2026
$4.01
$5.08
-5.40%
May 2026
$7.58
$5.37
-37.27%
Apr 2026
$7.88
$8.56
+0.12%
Mar 2026
$9.65
$8.55
-13.94%
Feb 2026
$11.73
$9.94
-5.47%
Jan 2026
$7.16
$10.51
+58.16%
Dec 2025
$9.75
$6.64
-26.62%

TransCode Share Price FAQs